Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Radiother Oncol. 2008 Jun;87(3):361-6. doi: 10.1016/j.radonc.2008.04.001. Epub 2008 Apr 23.

Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.

Author information

  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Abstract

S-1 is a novel, oral fluoropyrimidine and a known radiosensitizer. We conducted a phase I trial to establish a schedule of S-1/irinotecan with standard pelvic radiotherapy as a preoperative treatment of locally advanced rectal cancer. Our findings suggest that this new combination is feasible and well tolerable.

PMID:
18439695
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk